Up-regulation of Dicer, a Component of the MicroRNA Machinery, in Prostate Adenocarcinoma

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2006 Oct 31

PMID 17071602

Citations 163

Authors

Simion Chiosea

Elena Jelezcova

Uma Chandran

Marie Acquafondata

Teresa McHale

Robert W Sobol

Rajiv Dhir

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are small noncoding 18- to 24-nt RNAs that are predicted to regulate expression of as many as 30% of protein-encoding genes. In prostate adenocarcinoma, 39 microRNAs are up-regulated, and six microRNAs are down-regulated. Production and function of microRNA requires coordinated processing by proteins of the microRNA machinery. Dicer, an RNase III endonuclease, is an essential component of the microRNA machinery. From a gene array analysis of 16 normal prostate tissue samples, 64 organ-confined, and four metastatic prostate adenocarcinomas, we identified an up-regulation of major components of the microRNA machinery, including Dicer, in metastatic prostate adenocarcinoma. Immunohistochemical studies on a tissue microarray consisting of 232 prostate specimens confirmed up-regulation of Dicer in prostatic intraepithelial neoplasia and in 81% of prostate adenocarcinoma. The increased Dicer level in prostate adenocarcinoma correlated with clinical stage, lymph node status, and Gleason score. Western blot analysis of benign and neoplastic prostate cell lines further confirmed Dicer up-regulation in prostate adenocarcinoma. Dicer up-regulation may explain an almost global increase of microRNA expression in prostate adenocarcinoma. The presence of up-regulated microRNA machinery may predict the susceptibility of prostate adenocarcinoma to RNA interference-based therapy.

Citing Articles

Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy.

Park M, Choi J, Maharub Hossain Fahim M, Asevedo E, Nurkolis F, Ribeiro R Front Pharmacol. 2025; 16:1504618.

PMID: 40034825 PMC: 11872924. DOI: 10.3389/fphar.2025.1504618.

Analysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases.

Kalia P, Nair R, Yadav S Discov Oncol. 2025; 16(1):21.

PMID: 39776001 PMC: 11711428. DOI: 10.1007/s12672-025-01748-4.

MicroRNA in prostate cancer: from biogenesis to applicative potential.

Luo X, Wen W BMC Urol. 2024; 24(1):244.

PMID: 39506720 PMC: 11539483. DOI: 10.1186/s12894-024-01634-1.

The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers.

Wang F, Zhou C, Zhu Y, Keshavarzi M Cell Biol Toxicol. 2024; 40(1):42.

PMID: 38836981 PMC: 11153289. DOI: 10.1007/s10565-024-09884-3.

Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.

Lau B, Almeda A, Schauer M, McNamara M, Bai X, Meng Q Genome Med. 2023; 15(1):33.

PMID: 37138315 PMC: 10155347. DOI: 10.1186/s13073-023-01178-3.

References

Fukagawa T, Nogami M, Yoshikawa M, Ikeno M, Okazaki T, Takami Y . Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat Cell Biol. 2004; 6(8):784-91. DOI: 10.1038/ncb1155. View

Kaul D, Sikand K . Defective RNA-mediated c-myc gene silencing pathway in Burkitt's lymphoma. Biochem Biophys Res Commun. 2003; 313(3):552-4. DOI: 10.1016/j.bbrc.2003.12.002. View

Stone K, Mickey D, Wunderli H, MICKEY G, Paulson D . Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer. 1978; 21(3):274-81. DOI: 10.1002/ijc.2910210305. View

Yi R, Qin Y, Macara I, Cullen B . Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003; 17(24):3011-6. PMC: 305252. DOI: 10.1101/gad.1158803. View

Jin P, Zarnescu D, Ceman S, Nakamoto M, Mowrey J, Jongens T . Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci. 2004; 7(2):113-7. DOI: 10.1038/nn1174. View

Carmichael J, Provost P, Ekwall K, Hobman T . ago1 and dcr1, two core components of the RNA interference pathway, functionally diverge from rdp1 in regulating cell cycle events in Schizosaccharomyces pombe. Mol Biol Cell. 2003; 15(3):1425-35. PMC: 363162. DOI: 10.1091/mbc.e03-06-0433. View

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H . Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64(11):3753-6. DOI: 10.1158/0008-5472.CAN-04-0637. View

Yu Y, Landsittel D, Jing L, Nelson J, Ren B, Liu L . Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004; 22(14):2790-9. DOI: 10.1200/JCO.2004.05.158. View

Bonkhoff H . Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur Urol. 1996; 30(2):201-5. DOI: 10.1159/000474170. View

10.

Bello D, Webber M, Kleinman H, Wartinger D, Rhim J . Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis. 1997; 18(6):1215-23. DOI: 10.1093/carcin/18.6.1215. View

11.

Reiter R, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E . Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A. 1998; 95(4):1735-40. PMC: 19171. DOI: 10.1073/pnas.95.4.1735. View

12.

Jin P, Alisch R, Warren S . RNA and microRNAs in fragile X mental retardation. Nat Cell Biol. 2004; 6(11):1048-53. DOI: 10.1038/ncb1104-1048. View

13.

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

14.

Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk R, Cuppen E . Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005; 120(1):21-4. DOI: 10.1016/j.cell.2004.12.031. View

15.

Izquierdo M . Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther. 2004; 12(3):217-27. DOI: 10.1038/sj.cgt.7700791. View

16.

Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K . Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005; 96(2):111-5. PMC: 11158408. DOI: 10.1111/j.1349-7006.2005.00015.x. View

17.

Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

18.

Jaronczyk K, Carmichael J, Hobman T . Exploring the functions of RNA interference pathway proteins: some functions are more RISCy than others?. Biochem J. 2005; 387(Pt 3):561-71. PMC: 1134985. DOI: 10.1042/BJ20041822. View

19.

Gregory R, Shiekhattar R . MicroRNA biogenesis and cancer. Cancer Res. 2005; 65(9):3509-12. DOI: 10.1158/0008-5472.CAN-05-0298. View

20.

ODonnell K, Wentzel E, Zeller K, Dang C, Mendell J . c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435(7043):839-43. DOI: 10.1038/nature03677. View